FDA approval of AstraZeneca lupus drug sets up competition with GSK’s Benlysta August 2, 2021 Auto Bot AstraZeneca, BioPharma, biopharma nl, Cambridge, Clinical Trials, FDA, lupus, Pharma, Saphnelo, United Kingdom 0 An AstraZeneca lupus drug has been awarded FDA approval for treating the most common form of the autoimmune disorder. The regulatory decision gives AstraZeneca a product that can compete head-to-head with GlaxoSmithKline’s lupus drug, Benlysta.